VIDEO: Women with NASH-cirrhosis at higher risk for polypharmacy to manage chronic pain

WASHINGTON — In a Healio video exclusive, Leen Al-Sayyed, MD, gastroenterology and transplant hepatology fellow at St. Louis University, reported women with nonalcoholic steatohepatitis-cirrhosis had an increased prevalence for polypharmacy.Specifically, in the real-world, longitudinal observational cohort from the TARGET-NASH study, Al-Sayyed and colleagues found 75% of patients were treated with more than five medication and 37% were prescribed 10 or more medications (69% women) with the median number of medications used higher among women compared with men (9 vs. 7).“PatientsRead More

Generated by Feedzy